Caixin
Apr 30, 2022 08:00 AM

Shanghai Hile Bio-Technology Co.,Ltd.’s Net Profit Rose 10.2% in First Quarter of 2022

Shanghai Hile Bio-Technology Co.,Ltd. (上海海利生物技术股份有限公司) (603718.SH) reported a net profit of 11.3 million yuan in the first quarter of 2022, up 10.2% year-on-year.

Meanwhile, the company posted 85.1 million yuan in revenue, down 15.8% year-on-year.

At the end of the reporting period, it had 1.8 billion yuan in total assets and 822.9 million yuan in total liabilities, with a liability-to-asset ratio of 45.2%.

Share this article
Open WeChat and scan the QR code
NEWSLETTERS
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription
PODCAST
China Business Uncovered Podcast: Inside Vanke and China’s Property Reckoning
00:00
00:00/00:00